FDA Approved: BUMETANIDE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved Sandoz Inc's supplemental application for bumetanide (generic) under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Edema
• Heart Failure
• Hepatic Cirrhosis
• Nephrotic Syndrome

Drugs mentioned

• BUMETANIDE (bumetanide)

Snippet

SUPPL AP for BUMETANIDE (BUMETANIDE)